MP09-19 PSA KINETICS IN INITIAL ANDROGEN DEPRIVATION THERAPY IS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER

Itsuto Hamano,Shingo Hatakeyama,Shintaro Narita,Masahiro Takahashi,Toshihiko Sakurai,Sadafumi Kawamura,Senji Hoshi,Masanori Ishida,Toshiaki Kawaguchi,Shigeto Ishidoya,Jiro Shimoda,Hiromi Sato,Koji Mitsuzuka,Tatsuo Tochigi,Norihiko Tsuchiya,Yoichi Arai,Tomonori Habuchi,Chikara Ohyama

MP09-19 PSA KINETICS IN INITIAL ANDROGEN DEPRIVATION THERAPY IS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER

2020

Itsuto Hamano
Shingo Hatakeyama
Shintaro Narita
Masahiro Takahashi
Toshihiko Sakurai
Sadafumi Kawamura
Senji Hoshi
Masanori Ishida
Toshiaki Kawaguchi
Shigeto Ishidoya
Jiro Shimoda
Hiromi Sato
Koji Mitsuzuka
Tatsuo Tochigi
Norihiko Tsuchiya
Yoichi Arai
Tomonori Habuchi
Chikara Ohyama

INTRODUCTION AND OBJECTIVE:We determine whether the nadir prostate-specific antigen level (PSA nadir) and time to nadir (TTN) during initial androgen deprivation therapy (ADT) are prognostic factor...

Keywords:

Androgen deprivation therapy
Prostate cancer
prognostic factor
Urology
in patient
castration resistant
Medicine
psa kinetics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations